title: Prostate cancer.
abstract: Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
authors.affiliation: Department of Surgery, University of Wisconsin Medical School, Madison, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Hahnfeld
authors.forename: T D
authors.initials: TD
authors.lastname: Moon
mesh_terms: D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000379:methods; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000517:prevention & control / Q000628:therapy
chemical_list: D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen